Excel Biopharm

Excel BioPharm, LLC is researching the cloning capabilities of immunized animals without using hybridomas. The company's technology platform can reliably and efficiently generate antibodies against multi-transmembrane proteins such as GPCRs, transporters, and ion channels, and provides customized antibody therapies, enabling customers to develop high-quality antibodies for research, in vitro diagnostics, and therapeutic applications.